ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026
Cancer specific health utilities - QLU-C10D country value sets for Belgium, Hungary, Portugal and the Republic of Korea - an international valuation study.
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe QLU-C10D is a preference-based measure of health-related quality of life (HRQL) for health economic evaluation in cancer patients. QLU-C10D health state utility values (HSUV) are estimated from QLQ-C30 data weighted by country-specific value sets. To further integrate the QLU-C10D in the international health-economic landscape, we developed country value sets for Belgium, Hungary, Portugal, and the Republic of Korea.
methodsIn each country, online quota sampling was deployed to enrol participants representative of the general population for sex- and age- groups. We assessed socioeconomic information of participants. The standard EORTC QLU-C10D valuation protocol, a discrete-choice experiment, was used to elicit the country-specific value sets. Conditional logistic regressions were used to estimate general population preferences for survival time and impaired health domains. Utility decrements were estimated as the ratio of the coefficient for impaired health domains and the time coefficient. We used weighting to adjust for oversampling of higher education participants.
resultsBetween September 2023 and February 2024, 4074 participants from the four countries were enrolled and included in analyses. Participants in all countries showed the greatest preference for the health domain of ‘physical functioning’, resulting in utility decrements of -0.182 to -0.372 for the impairment level ‘very much’. This was followed by the health domains of ‘Pain’, ‘Role Functioning’, and ‘Social Functioning’, which ranged between − 0.096 to -0.190 for the impairment level ‘very much’ across the four countries. Non-monotonicities were observed in all four countries, thus adjustments for non-monotonicity were performed for each country value set.
conclusionThe value sets of the QLU-C10D for the countries of Belgium, Hungary, Portugal and the Republic of Korea allow health-decision makers in these countries to estimate cancer-specific HSUVs, thereby incorporating the HRQL data collected with the QLQ-C30 into health economic decision-making.
Indexed as
Identifiers
42018122What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.